Drug Shortage Report for APRESOLINE

Last updated on 2023-11-09 History
Report ID 91935
Drug Identification Number 00723754
Brand name APRESOLINE
Common or Proper name HYDRALAZINE HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC
Market Status DORMANT
Active Ingredient(s) HYDRALAZINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code C02DB
ATC description ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-08-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-11-09
Company comments Resupply date is unknown.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2023-11-09 French Compare
v33 2023-11-09 English Compare
v32 2023-09-29 English Compare
v31 2022-04-08 French Compare
v30 2022-04-08 English Compare
v29 2022-04-08 French Compare
v28 2022-04-08 English Compare
v27 2022-01-14 French Compare
v26 2022-01-14 English Compare
v25 2022-01-14 French Compare
v24 2022-01-14 English Compare
v23 2022-01-13 English Compare
v22 2021-10-26 French Compare
v21 2021-10-26 English Compare
v20 2021-10-18 French Compare
v19 2021-10-18 English Compare
v18 2021-02-01 French Compare
v17 2021-02-01 English Compare
v16 2021-01-27 French Compare
v15 2021-01-27 English Compare

Showing 1 to 20 of 34